TrialAmerican journal of hematology2012

A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease.

Abdullah Kutlar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.